Synthaverse S.A. (WSE:SVE)
3.920
-0.100 (-2.49%)
Nov 21, 2025, 5:00 PM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 277.42 million as of November 21, 2025. Its market cap has decreased by -9.25% in one year.
Market Cap
277.42M
Enterprise Value
366.78M
Revenue
71.76M
Ranking
n/a
PE Ratio
62.08
Stock Price
3.92
Market Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 277.42M, an increase of 92.65%. That is a compound annual growth rate of 4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 277.42M | -12.66% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | 557.85M | 753.33% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.94B |
| NEUCA | 3.62B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.51B |
| Celon Pharma | 1.08B |
| Selvita | 805.81M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Bioceltix | 447.63M |